Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Light Chain (AL) Amyloidosis”

39 trials

Showing 20 of 39 results

Not applicableStudy completedNCT02555969
What this trial is testing

Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis

Who this might be right for
AmyloidosisPrimary Amyloidosis
Tufts Medical Center 56
Testing effectiveness (Phase 2)Study completedNCT00547365
What this trial is testing

Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
University of Tennessee 10
Testing effectiveness (Phase 2)Study completedNCT00091260
What this trial is testing

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Vaishali Sanchorawala 82
Large-scale testing (Phase 3)Ended earlyNCT02312206
What this trial is testing

The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis

Who this might be right for
Primary Systemic (AL) Amyloidosis
Prothena Biosciences Ltd. 260
Testing effectiveness (Phase 2)Study completedNCT01510613
What this trial is testing

Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia 28
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Testing effectiveness (Phase 2)Study completedNCT00981708
What this trial is testing

Lenalidomide, Dexamethasone and Cyclophosphamide in Amyloidosis (AL)

Who this might be right for
Amyloidosis
University of Athens 37
Testing effectiveness (Phase 2)Study completedNCT01707264
What this trial is testing

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
Primary Amyloidosis
Prothena Biosciences Ltd. 69
Large-scale testing (Phase 3)Study completedNCT00344526
What this trial is testing

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Who this might be right for
Primary Systemic Amyloidosis (AL)
University Hospital, Limoges 100
Testing effectiveness (Phase 2)Study completedNCT00679367
What this trial is testing

Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00075608
What this trial is testing

2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Boston Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00003853
What this trial is testing

4'-Iodo-4'-Deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00064337
What this trial is testing

S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network 104
Testing effectiveness (Phase 2)WithdrawnNCT01531751
What this trial is testing

High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia
Testing effectiveness (Phase 2)Study completedNCT00002849
What this trial is testing

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 93
Testing effectiveness (Phase 2)Study completedNCT00883623
What this trial is testing

A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis

Who this might be right for
Primary Amyloidosis
Heidelberg University 50
Testing effectiveness (Phase 2)UnknownNCT03252600
What this trial is testing

Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis

Who this might be right for
Recurrent Primary Amyloidosis
Barbara Ann Karmanos Cancer Institute 53
Testing effectiveness (Phase 2)Study completedNCT00075621
What this trial is testing

Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 62
Testing effectiveness (Phase 2)Study completedNCT01083316
What this trial is testing

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 35
Early research (Phase 1)Ended earlyNCT01728259
What this trial is testing

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
Barbara Ann Karmanos Cancer Institute 18
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation